Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Coenzyme Q10 in nanocarriers improves treatment for hair loss.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Tangent screens help detect visual field defects from vigabatrin.

Rituximab can cause skin issues, but baricitinib may help improve them.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Finasteride and dutasteride might lower melanoma risk.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Small injections of dutasteride improved hair thickness in men with hair loss without major side effects.

MOTILIPERM may help treat male infertility by reducing stress in cells.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.